Apnea and respiratory insufficiency after intraperitoneal administration of kanamycin.
D000900:Anti-Bacterial Agents / Q000633:toxicity*; D001049:Apnea / Q000209:etiology*; D006801:Humans; D007274:Injections, Intraperitoneal; D007612:Kanamycin; D012119:Respiration / Q000494:pharmacology*; D012131:Respiratory Insufficiency
D000900:Anti-Bacterial Agents; D007612:Kanamycin
ANTIBIOTICS/toxicology; APNEA/etiology; RESPIRATION/pharmacology